Amphioxus Cell Technologies, Incyte Pharmaceuticals Inc. deal

Amphioxus, a liver biology company, granted INCY an exclusive access to its C3A cloned human liver cell line, which simulates liver responses to drug and stress stimuli. INCY will use C3A to generate...